Valuation: Grand Pharmaceutical Group Limited

Market Cap 16.67B 2.12B 1.86B 1.76B 1.6B 3B 204B 3.03B 21.07B 8.16B 104B 7.98B 7.81B 334B P/E 2026 *
9.24x
P/E 2027 * 8.46x
Enterprise Value 16.67B 2.12B 1.86B 1.76B 1.6B 3B 204B 3.03B 21.07B 8.16B 104B 7.98B 7.81B 334B EV / Sales 2026 *
1.29x
EV / Sales 2027 * 1.18x
Free-Float
34.99%
Yield 2026 *
4.41%
Yield 2027 * 4.83%
1 day-1.45%
1 week-2.56%
Current month-5.18%
1 month-9.85%
3 months+2.37%
6 months-28.53%
Current year-39.36%
1 week 4.65
Extreme 4.65
5.06
1 month 4.65
Extreme 4.65
5.66
Current year 4.53
Extreme 4.53
8.18
1 year 4.53
Extreme 4.53
8.97
3 years 3.17
Extreme 3.17
10.2
5 years 3.17
Extreme 3.17
10.2
10 years 1.36
Extreme 1.36
10.2
Manager TitleAgeSince
Chief Executive Officer 36 01/06/2021
Corporate Secretary 57 01/09/2011
Director TitleAgeSince
Director/Board Member 63 21/03/2005
Director/Board Member 66 12/05/2011
Director/Board Member 62 31/12/2018
Date Insider Type Main position Quantity % Market Cap. Importance
07/09/26 Other

Chief Executive Officer

21,500 0.0006%
22/04/26 Other

Chairman

50,000 0.0014%
21/04/26 Other

Chief Executive Officer

58,500 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-1.45%-2.56%-43.33%+14.15% 2.12B
+0.13%+2.65%+65.61%+114.28% 1,055B
+0.20%+0.46%+52.60%+69.24% 654B
-0.29%+0.14%+20.96%+70.93% 467B
-0.85%+0.98%+41.29%+44.38% 348B
+0.71%+4.08%+22.24%+29.51% 275B
+1.23%+0.42%+14.57%+12.13% 258B
+2.11%+7.51%+52.89%+55.37% 224B
+0.83%+0.55%+35.99%+101.70% 187B
0.00%-10.14%-29.94%-60.30% 171B
Average +0.18%+0.41%+23.29%+45.14% 364.05B
Weighted average by Cap. +0.02%+1.31%+41.49%+67.80%

Financials

2026 *2027 *
Net sales 12.94B 1.65B 1.45B 1.37B 1.25B 2.33B 158B 2.35B 16.36B 6.34B 80.8B 6.2B 6.06B 260B 14.1B 1.8B 1.58B 1.49B 1.36B 2.54B 172B 2.56B 17.83B 6.91B 88.03B 6.75B 6.6B 283B
Net income 1.83B 233M 204M 193M 176M 329M 22.32B 332M 2.31B 894M 11.4B 874M 855M 36.64B 1.99B 254M 223M 210M 192M 359M 24.33B 361M 2.52B 975M 12.43B 953M 932M 39.94B
Net Debt - -
Logo Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
Employees
12,326
Date Price Change Volume
25/09/26 HK$4.760 -1.45% 1,635,000
24/09/26 HK$4.830 -1.53% 5,401,500
23/09/26 HK$4.905 -0.51% 3,689,500
22/09/26 HK$4.930 -1.50% 4,690,500
21/09/26 HK$5.005 +2.46% 9,687,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.760HKD
Average target price
9.527HKD
Spread / Average Target
+100.14%

Annual profits - Rate of surprise